In 2023, the share of the UK's scientific publications among the top-cited 10% in drug discovery was stable. The forecasted data for 2024 to 2028 shows a gradual increase from 14.51% to 14.68%. The year-on-year growth is modest, indicating the UK's consistent contribution to high-impact drug discovery research. Over five years, the CAGR is expected to be minimal, reflecting a steady influence in the field.
Future trends to watch for:
- Potential impact of increased collaboration with international partners.
- Investment in innovative research techniques and technologies.
- Policy changes that could affect research funding and focus.
